GAM Multistock Swiss Equity CHF R acc
Performance (in CHF)
Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.
Performance
1 month | 8.14% |
---|---|
Current year | 2.17% |
3 years p.a. | 3.84% |
5 years p.a. | 7.94% |
10 years p.a. | n.a. |
Since inception p.a. | n.a. |
Rolling performance in %
Key figures
YTD | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Performance | 2.17% | 1.91% | 11.98% | 46.53% | n.a. |
Maximum profit on monthly basis | 9.31% | 9.31% | 9.31% | 10.08% | n.a. |
Maximum loss on monthly basis | -4.68% | -5.05% | -9.83% | -9.83% | n.a. |
Max drawdown | -20.21% | -20.21% | -20.21% | -33.49% | n.a. |
Volatility | 22.75% | 17.38% | 16.29% | 16.45% | n.a. |
Sharpe ratio | 0.17 | -0.04 | 0.04 | 0.41 | n.a. |
Maximum continuous profit in months | 2 | 2 | 4 | 10 | n.a. |
Maximum continuous loss in months | 2 | 4 | 4 | 4 | n.a. |
Positive months / profit duration in months | 3 | 6 | 19 | 36 | n.a. |
Negative months / loss duration in months | 2 | 7 | 18 | 25 | n.a. |
Master data
Fund name | GAM Multistock Swiss Equity CHF R acc |
---|---|
Fund management company | GAM (Luxembourg) S.A. |
Fund domicile | Luxembourg |
Inception date | 21 February 2018 |
ISIN | LU1774054420 |
Swiss security no. | 40429722 |
Fund currency | CHF |
Appropriation of income | accumulating |
Ongoing charges under PRIIP KID as at 04 April 2024 | 0.75% |
End of financial year | 30 June |
Fund volume as at 30 December 2024 | 193.87 Mio. CHF |
Net asset value (NAV) as at 06 May 2025 | 152.36 CHF |
Portfolio structure
Top holdings of fund volume (in %)
Roche Holdings AG | 9.48% | |
Novartis AG | 7.80% | |
ABB Ltd.-Reg. | 5.60% | |
UBS Group AG | 5.13% | |
Nestle SA | 4.82% | |
Holcim AG | 4.60% | |
Financiere Richemont | 4.13% | |
Sika AG | 3.94% | |
Sonova Holding | 3.78% | |
Logitech Int. | 3.57% |